Abstract
Troponin I is a sensitive and specific marker for the diagnosis of myocardial infarction. Several commercially available immunoassays measure the concentration of troponin I in serum. The microparticle enzyme immunoassay (MEIA) for troponin I (Abbott Laboratories, Abbott Park, IL) is widely used in clinical laboratories, including our hospital laboratory. We studied the effect of bilirubin and hemolysis on the MEIA for troponin I and compared our assay with a newly available chemiluminescent assay (CLIA) for troponin I (Bayer Diagnostics, Tarrytown, NY). We also measured CK‐MB concentration using the MEIA CK‐MB assay. One serum pool was prepared by combining several specimens of one patient with elevated troponin I and with a diagnosis of myocardial infarction. Other serum pools were prepared by combining sera with similar troponin I values. All serum pools showed normal bilirubin concentrations and had no hemolysis. Then we supplemented aliquots of serum pools with various concentrations of bilirubin (5.0, 10.0, 15.0, and 20.0 mg/dL). After supplementation, troponin I concentrations were measured again using the MEIA and CLIA. We observed a statistically significant decrease in troponin I concentration in the presence of bilirubin with the MEIA. For example, in serum pool 1, the troponin I concentration was 16.3 (bilirubin: 0.8 mg/dL). In the presence of 5.0, 10.0, 15.0 and 20.0 mg/dL of added bilirubin, the cardiac troponin I concentrations were 13.9, 13.4, 13.3 and 13.0 ng/ml respectively. We observed similar negative interference of bilirubin in troponin I measurement by the MEIA in other pools. The troponin I value decreased slightly (not statistically significant) in one pool and did not change in two other pools in the presence of bilirubin when we measured troponin I concentration using the CLIA. Interestingly, bilirubin did not interfere with the MEIA CK‐MB assay. Moderate hemolysis did not have any effect on the troponin I assay using either the MEIA or CLIA. However, gross hemolysis (hemoglobin > 40 mg/dL) interfered with both assays for troponin I. J. Clin. Lab. Anal. 15:76–80, 2001. © 2001 Wiley‐Liss, Inc.
Keywords: troponin I, microparticle enzyme immunoassay, bilirubin, hemolysis
references
- 1. Dorogy ME, Hooks GS, Cameron RW, Davis RC. 1995. Clinical and angiographic correlates of normal creatinine kinase with increased MB isoenzymes in possible acute myocardial infarction. Am Heart J 130:211–217. [DOI] [PubMed] [Google Scholar]
- 2. Hong RA, Litch JD, Wei Y, et al. 1986. Elevated CK‐MB with normal total creatinine kinase in suspected myocardial infarction: associated clinical findings and early prognosis. Am Heart J 111:1041–1046. [DOI] [PubMed] [Google Scholar]
- 3. Guest TG, Ramanathan AV, Tuteur PG, et al. 1995. Myocardial injury in critically ill patients; a frequent unrecognized complication. JAMA 273:1945–1949. [PubMed] [Google Scholar]
- 4. Cohen LF, Mohabeer AJ, Keffer JH, Jialal I. 1996. Troponin I in hypothyroidism. Clin Chem 42:1494–1495. [PubMed] [Google Scholar]
- 5. Beck SR. 1995. Myocardial injury in critically ill patients [letter]. JAMA 274:1672–1673. [DOI] [PubMed] [Google Scholar]
- 6. Li D, Jialal I, Keffer JH. 1996. Greater frequency of increased cardiac troponin I than increased cardiac troponin T in patients with chronic renal failure. Clin Chem 42:114–115. [PubMed] [Google Scholar]
- 7. Keffer JH. 1997. The cardiac profile and proposed practice guideline for acute ischemic heart disease. Am J Clin Pathol 107:398–409. [DOI] [PubMed] [Google Scholar]
- 8. Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. 1995. Cardiac troponin I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 41:1710–1715. [PubMed] [Google Scholar]
- 9. ver Elst KM, Chapelle JP, Boland P, Demolder JS, Gorus FK. 1999. Analytical and clinical evaluation of the Abbott AxSYM cardiac troponin I assay. Am J Clin Pathol 112:745–752. [DOI] [PubMed] [Google Scholar]
- 10. Bock JL. 1999. Cardiac troponin . How specific is specific? Am J Clin pathol 112:739–741. [DOI] [PubMed] [Google Scholar]
- 11. Dasgupta A, Banerjee S, Datta P. 1999. False positive troponin I in the MEIA due to the presence of rheumatoid factors in serum: elimination of this interference by using a polyclonal antisera against rheumatoid factors. Am J Clin Pathol 112:753–756. [DOI] [PubMed] [Google Scholar]
- 12. Glick MR, Ryder K, Jackson S. 1986. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 32:470–475. [PubMed] [Google Scholar]
- 13. Adams JE, Bodor GS, Davilla‐Roman, et al. 1993. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 88:101–106. [DOI] [PubMed] [Google Scholar]
- 14. D’Costa M, Fleming E, Patterson MC. 1997. Cardiac troponin I for the diagnosis of acute myocardial infarction in emergency department. Am J Clin Pathol 108:550–555. [DOI] [PubMed] [Google Scholar]
- 15. Cina SJ, Li DJ, Chan DW, et al. 1998. Serum concentrations of cardiac troponin I in sudden death: a pilot study. Am J Forensic Med 19:324–328. [DOI] [PubMed] [Google Scholar]
- 16. Dasgupta A, Chow L, Nazareno L, Tso G, Datta P. 2000. Performance evaluation of a new chemiluminescent cardiac troponin I assay. J Clin Lab Anal 14:224–229. [DOI] [PMC free article] [PubMed] [Google Scholar]